<DOC>
	<DOCNO>NCT00989443</DOCNO>
	<brief_summary>Human Papilloma Virus ( HPV ) infection induce cervical intraepithelial neoplasia ( CIN ) cervix . To reduce incidence invasive tumor associate high grade CIN lesion , standard treatment conisation cervix ( surgical act ) . A local treatment antiviral anti-proliferative cidofovir would preserve cervix young subject reduce obstetrical morbidity induce conisation . This clinical study aim : 1. evaluate tolerance safety cidofovir gel directly apply cervix exhibit high grade CIN lesion ; 2. evaluate pharmacokinetic ( PK ) profile cidofovir local application .</brief_summary>
	<brief_title>Safety Tolerability Cidofovir Gel Applied Cervix Squamous Lesions</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>woman age 18 50 year old volunteer inform consent sign cervical lesion classify CIN 2 3 , biopsy make 6 preceding week sexual activity use effective mechanical , hormonal intrauterine contraception ( except hormonal vaginal ring ) pregnancy breast feed subtotal hysterectomy current ancient renal impairment current immune disorder current use drug interfere renal function current treatment cancer current use treatment interfere immunity current use antiviral treatment current recent participation another experimental study last 3 month screen visit current vaginal application drug cosmetic local general condition incompatible experimental treatment opinion principal investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Cervix Intraepithelial Neoplasia grade 2 3</keyword>
</DOC>